HealthEquity, Inc. (NASDAQ:HQY) Shares Purchased by Swiss National Bank

Swiss National Bank lifted its position in HealthEquity, Inc. (NASDAQ:HQY) by 0.4% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 169,900 shares of the company’s stock after acquiring an additional 600 shares during the period. Swiss National Bank owned 0.19% of HealthEquity worth $13,906,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently made changes to their positions in HQY. O Shaughnessy Asset Management LLC increased its position in shares of HealthEquity by 3.9% in the 1st quarter. O Shaughnessy Asset Management LLC now owns 5,219 shares of the company’s stock valued at $426,000 after acquiring an additional 197 shares during the period. Bessemer Group Inc. increased its position in shares of HealthEquity by 19.2% in the 1st quarter. Bessemer Group Inc. now owns 2,838 shares of the company’s stock valued at $231,000 after acquiring an additional 457 shares during the period. CANADA LIFE ASSURANCE Co increased its position in shares of HealthEquity by 2.1% in the 1st quarter. CANADA LIFE ASSURANCE Co now owns 65,666 shares of the company’s stock valued at $5,360,000 after acquiring an additional 1,344 shares during the period. Shell Asset Management Co. acquired a new stake in HealthEquity during the 1st quarter worth about $233,000. Finally, Price T Rowe Associates Inc. MD grew its position in HealthEquity by 7.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 51,384 shares of the company’s stock worth $4,195,000 after purchasing an additional 3,365 shares during the period. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Trading Down 0.4 %

Shares of HealthEquity stock opened at $104.25 on Friday. The firm has a market capitalization of $9.10 billion, a PE ratio of 86.36, a P/E/G ratio of 1.61 and a beta of 0.52. HealthEquity, Inc. has a twelve month low of $62.10 and a twelve month high of $105.73. The firm’s 50-day moving average price is $87.22 and its 200 day moving average price is $81.73. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share for the quarter, beating analysts’ consensus estimates of $0.50 by $0.16. The firm had revenue of $299.93 million for the quarter, compared to analyst estimates of $284.48 million. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. On average, sell-side analysts predict that HealthEquity, Inc. will post 2.27 EPS for the current fiscal year.

Insider Activity at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction that occurred on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the transaction, the director now directly owns 54,719 shares of the company’s stock, valued at $4,540,582.62. This trade represents a 13.10 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Frank Corvino sold 1,247 shares of the firm’s stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total transaction of $100,084.22. Following the completion of the transaction, the director now directly owns 4,823 shares in the company, valued at $387,093.98. This trade represents a 20.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 10,536 shares of company stock valued at $884,517. 2.20% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the company. JMP Securities reaffirmed a “market outperform” rating and set a $105.00 price target on shares of HealthEquity in a research report on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft increased their price target on HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, September 4th. Barrington Research reaffirmed an “outperform” rating and set a $105.00 price target on shares of HealthEquity in a research report on Friday, September 20th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $92.00 price target on shares of HealthEquity in a research report on Wednesday, September 4th. Finally, The Goldman Sachs Group began coverage on HealthEquity in a research report on Friday, November 15th. They set a “neutral” rating and a $108.00 price target on the stock. One equities research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, HealthEquity currently has an average rating of “Moderate Buy” and an average price target of $107.23.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.